Incubation 2-5 days
Enters the body through a wound
Incubation 3-21 days
Bacteria Respiratory transmission
Incubation 5-10 days
Inactivated polysaccharide vaccine, containing diphtheria toxoid, tetanus toxoid & acellular pertussis. This vaccine is licensed for administration only to children 6 weeks through 6 years of age. If child is 7 years of age or older, only Td and Tdap vaccines should be administered. (See Td/Tdap section of this booklet)
Dose & Route
0.5 mL given IM
Dose Recommended Age
Dose 1 @ 2 months
Dose 2 @ 4 months
Dose 3 @ 6 months
Dose 4* @15-18 mo (1st booster dose)
Dose 5* @ 4-6 yrs (2nd booster dose)
*Dose #4 may be administered at 12 months of age if separated by at least 6 months from Dose #3. Dose #4 does not need to be repeated if it has been inadvertently administered ≥4 months after Dose #3.
The #5 Booster Dose is not needed if Dose #4 is given on or after the 4th birthday.
Dose 1 @ 6 weeks of age
Dose 2 @ 4 weeks from dose 1
Dose 3 @ 4 weeks from dose 2
Dose 4 @ No less than 6 months from dose 3
Dose 5* @ No less than 6 months from dose 4
- *15 – 18 months of age
- *4 – 6 years of age
- 11 – 12 years of age
- Tdap vaccine should be given as a booster at 11-12 years of age. Tdap may be administered regardless of the interval since the last tetanus-and diphtheria-toxoid- containing vaccine (See Td/Tdap section of this booklet)
- A dose of Tdap or DTaP administered at 10 years of age may now be counted as the adolescent Tdap
- A dose of Tdap or DTaP administered at 7 through 9 years of age should not be counted as the adolescent dose, and Tdap should be administered at 11-12 years of age.
- Two diphtheria, tetanus, and acellular pertussis vaccines (Tdap) are licensed:
- BoostrixTM for administration to persons 10 years of age and older
- AdacelTM for administration to persons 10-64 years of age
- Every 10 years thereafter for life
- Td or Tdap vaccine should be given every 10 years after the administration of Tdap at 11-12 years of age. (See Td/Tdap section of this booklet)
- Anaphylactic reaction to any of the vaccine components.
- Life threatening allergic reaction after a previous dose of DTaP or DT (Pediatric diphtheria and tetanus vaccine which is used in lieu of DTaP only if there is a contraindication to pertussis vaccine).
- Encephalopathy within 7 days of a previous dose not attributable to another identifiable cause.
- Acute, moderate, or severe illness with or without fever immunize as soon as illness subsides.
- Temperature of 105 degrees within 48 hours after a previous dose of DTP/DTaP.
- Collapse or shock-like state within 48 hours after receiving a previous dose of DTP/DTaP.
- Persistent, inconsolable crying lasting >3 hours, occurring within 48 hours.
- Convulsions with or without fever occurring within 3 days.
- Wound management in children less than age 7 years with history of 3 or more doses of tetanus-toxoid-containing vaccine: for all wounds except clean and minor wounds, administer DTaP if more than 5 years since last dose of tetanus-toxoid-containing vaccine.